Vaccine coverage in children, adolescents and adults with type 1 diabetes and their close contacts in Crete

Victoria Giatraki1, Helen Dimitriou1, Aggelos Pappas2

  • 1Department of Pediatrics, University Hospital of Heraklion, Medical School University of Crete, Greece.

Insights

Type 1 diabetes patients show good adherence to routine childhood vaccines but lower rates for adolescent and specific vaccines. Influenza vaccination is insufficient for both patients and their close contacts, indicating a need for targeted interventions.

Area of Science:

  • Immunology
  • Endocrinology
  • Public Health

Background:

  • Individuals with type 1 diabetes (T1D) face heightened risks of infections from vaccine-preventable diseases.
  • Assessing vaccination compliance in T1D patients and their contacts is crucial for public health strategies.

Purpose of the Study:

  • To evaluate vaccination coverage among T1D patients (children, adolescents, and adults) and their close contacts.
  • To identify factors influencing vaccination adherence and deviations from recommended schedules.

Main Methods:

  • Retrospective analysis of vaccination records, medical files, and telephone interviews from 258 T1D patients.
  • Assessment of demographic parameters, glycemic control, and influenza vaccination status of 605 close contacts.

Main Results:

  • High coverage for routine childhood vaccines (e.g., PCV, Hib, MMR), but lower rates for adolescent/group-specific vaccines (e.g., HPV, meningococcus ACWY, 23-valent pneumococcal).
  • Influenza vaccination coverage was 76.7% in children and 64.4% in adults; approximately 50% of close contacts remained unvaccinated.
  • Better glycemic control correlated with higher adherence to vaccination schedules and a more vaccinated family environment.

Conclusions:

  • While routine childhood vaccination is adequate, T1D patients require improved coverage for adolescent and specific vaccines.
  • Influenza vaccination rates are suboptimal for both T1D individuals and their close contacts.
  • Targeted interventions are necessary to enhance overall vaccination uptake in this vulnerable population.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.7K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
306
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.3K
Vaccinations01:51

Vaccinations

Overview
46.4K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
566